Thymic T-cell development in allogeneic stem cell transplantation

Blood

Volumn 117, Issue 25, 2011, Pages 6768-6776

  Krenger, Werner ^a   Blazar, Bruce R ^b   Holländer, Georg A ^a,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; CELL MATURATION; CELLULAR IMMUNITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS;

EID: 79959529827     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-334623     Document Type: Review

References (99)

1. Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol. 2009;16(6):420-426.
2. Ballen KK, King RJ, Chitphakdithai P, et al. The national marrow donor program: 20 years of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14(9 suppl):2-7.
3. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoieticcell transplantation. N Engl J Med. 2010;363(22):2091-2101.
4. Deeg HJ, Sandmaier BM. Who is fit for allogeneic transplantation? Blood. 2010;116(23):4762-4770.
5. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: II. CIBMTR Summary Slides 2009. CIBMTR Newsletter. 2009;15(2):7-11.
6. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: I. CIBMTR Summary Slides 2009. CIBMTR Newsletter. 2009;15(1):7-11.
7. Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood. 2009;114(1):7-19.
8. Baker KS, Bresters D, Sande JE. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am. 2010;57(1):323-342.
9. Turner BE, Collin M, Rice AM. Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to? Cytotherapy. 2010;12(4):440-454.
10. Storek J, Zhao Z, Lin E, et al. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clin Immunol. 2004;113(3):285-298. (Pubitemid 39422608)
11. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood. 2010;115(19):3861-3868.
12. Cavazzana-Calvo M, André-Schmutz I, Dal Cortivo L, Neven B, Hacein-Bey-Abina S, Fischer A. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress. Curr Opin Immunol. 2009;21(5):544-548.
13. Toubert A. Immune reconstitution after allogeneic HSCT. In:Hematopoietic Stem Cell Transplantation : The EBMT Handbook, 5th ed. Paris: European School of Haematology; 2008:296-306.
14. Saliba RM, Komanduri KV, Giralt S, et al. Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML. Bone Marrow Transplant. 2009;43(9):685-692.
15. Eyrich M, Wollny G, Tzaribaschev N, et al. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biol Blood Marrow Transplant. 2005;11(3):194-205. (Pubitemid 40287918)
16. + cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia. Blood. 2003;101(2):446-453.
17. Jiménez M, Ercilla G, Martínez C. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia. 2007;21(8):1628-1637. (Pubitemid 47090130)
18. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97(5):1458-166.
19. Jiménez M, Martínez C, Ercilla G, et al. Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults. Transpl Immunol. 2006;16(1):52-59.
20. Clave E, Busson M, Douay C, et al. Acute graft versus host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood. 2009;113(25):6477-6484.
21. Williams KM, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol. 2007;19(5):318-330. (Pubitemid 350181530)
22. Muraro PA, Douek DC. Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol. 2006;27(2):61-67. (Pubitemid 43221971)
23. Hakim FT, Gress RE. Reconstitution of the lymphocyte compartment after lymphocyte depletion: a key issue in clinical immunology. Eur J Immunol. 2005;35(11):3099-3102. (Pubitemid 41672514)
24. Gress RE, Komanduri KV, Einsele H, Cooper LJ. Lymphoid reconstruction and vaccines. Biol Blood Marrow Transplant. 2007;13(1 suppl 1):17-22. (Pubitemid 46044109)
25. Baron F, Sandmaier BM. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Leukemia. 2006;20(10):1690-1700. (Pubitemid 44590958)
26. Baron F, Baker JE, Storb R, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood. 2004;104(8):2254- 2262. (Pubitemid 39331820)
27. Bourgeois C, Stockinger B. T cell homeostasis in steady state and lymphopenic conditions. Immunol Lett. 2006;107(2):89-92. (Pubitemid 44779812)
28. Jameson SC. T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin Immunol. 2005;17(3):231-237. (Pubitemid 40488982)
29. Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood. 2000;96(6):2299-2303.
30. Chalandon Y, Degermann S, Villard J, et al. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood. 2006;107(1):389-396. (Pubitemid 43053568)
31. Storek J, Geddes M, Khan F, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30(4):425-437.
32. Rapoport AP, Stadtmauer EA, Aqui N, et al. Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nat Med. 2005;11(11):1230-1237. (Pubitemid 43093671)
33. June CH, Blazar BR, Riley JL. Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol. 2009;9(10):704-716.
34. Casalegno-Garduño R, Schmitt A, Wang X, Xu X, Schmitt M. Targeted cellular immunotherapy for leukemia patients. Transfus Apher Sci. 2010;43(2):207-210.
35. Ringdén O, Karlsson H, Olsson R, Omazic B, Uhlin M. The allogeneic graft-versus-cancer effect. Br J Haematol. 2009;147(5):614-633.
36. Krenger W, Holländer GA. The role of the thymus in hematopoietic stem cell transplantation. In: Bone Marrow Transplantation Across Genetic Barriers. In press.
37. Krenger W, Holländer GA. The immunopathology of thymic GVHD. Semin Immunopathol. 2008;30(4):439-456.
38. Vicente R, Swainson L, Marty-Grès S, et al. Molecular and cellular basis of T cell lineage commitment. Semin Immunol. 2010;22(5):270-275.
39. Carpenter AC, Bosselut R. Decision checkpoints in the thymus. Nat Immunol. 2010;11(8):666-673.
40. +) thymocytes in normal and genetically modified mice. J Immunol. 1995;154(10):5103-5113.
41. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6(2):127-135. (Pubitemid 43361588)
42. Petrie HT, Zúñiga-Pflücker JC. Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol. 2007;25:649-679. (Pubitemid 46697920)
43. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol. 1993;150(10):4244- 4252.
44. Gardner JM, Fletcher AL, Anderson MS, Turley SJ. AIRE in the thymus and beyond. Curr Opin Immunol. 2009;21(6):582-589.
45. Scollay R, Godfrey DI. Thymic emigration: conveyor belts or lucky dips? Immunol Today. 1995;16(6):268-273.
46. Castermans E, Hannon M, Dutrieux J, et al. Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica. 2011;96(2):298-306.
47. Nasseri F, Eftekhari F. Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls. Radiographics. 2010;30(2):413-428.
48. Berzins SP, Uldrich AP, Sutherland JS, et al. Thymic regeneration: teaching an old immune system new tricks. Trends Mol Med. 2002;8(10):469-476.
49. McCaughtry TM, Wilken MS, Hogquist KA. Thymic emigration revisited. J Exp Med. 2007;204(11):2513-2520. (Pubitemid 350044776)
50. Ribeiro RM, Perelson AS. Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data. Immunol Rev. 2007;216:21-34. (Pubitemid 46426513)
51. + lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest. 2010;120(5):1479-1493.
52. + T-cell subsets. Blood. 2009;113(4):769-774.
53. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396(6712):690-695. (Pubitemid 29003949)
54. Fry TJ. Is a little GVHD a good thing? Blood. 2009;113(25):6274-6275.
55. Poulin JF, Sylvestre M, Champagne P, et al. Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood. 2003;102(13):4600-4607. (Pubitemid 37494130)
56. Dion ML, Poulin JF, Bordi R, et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity. 2004;21(6):757-768. (Pubitemid 39626667)
57. Almeida AR, Borghans JA, Freitas AA. T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J Exp Med. 2001;194(5):591-599. (Pubitemid 32844770)
58. Krenger W, Holländer GA. The thymus in GVHD pathophysiology. Best Pract Res Clin Haematol. 2008;21:119-128. (Pubitemid 351712710)
59. Dorshkind K, Montecino-Rodriguez E, Signer RA. The ageing immune system: is it ever too old to become young again? Nat Rev Immunol. 2009;9(1):57-62.
60. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-764. (Pubitemid 40292986)
61. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol. 2009;30(7):366-373.
62. Heng TS, Chidgey AP, Boyd RL. Getting back at nature: understanding thymic development and overcoming its atrophy. Curr Opin Pharmacol. 2010;10(4):425-433.
63. Gray D, Seach N, Ueno T, et al. Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood. 2006;108(12):3777-3785. (Pubitemid 44864559)
64. Rosato E, Salsano F. Immunity, autoimmunity and autoimmune diseases in older people. J Biol Regul Homeost Agents. 2008;22(4):217-224.
65. Steinmann GG. Changes in the human thymus during aging. Curr Top Pathol. 1986;75:43-88.
66. Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Pharmacol. 2010;10(4):408-424.
67. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93(2):467-480. (Pubitemid 29035728)
68. Gui J, Zhu X, Dohkan J, Cheng L, Barnes PF, Su DM. The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int Immunol. 2007;19(10):1201-1211. (Pubitemid 47500643)
69. Jiménez M, Martínez C, Ercilla G, et al. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Exp Hematol. 2005;33(10):1240-1248. (Pubitemid 41416973)
70. Maris M, Boeckh M, Storer B, et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol. 2003;31(10):941-952. (Pubitemid 37211379)
71. Kelly RM, Highfill SL, Panoskaltsis-Mortari A, et al. Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood. 2008;111(12):5734-5744.
72. Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 2002;99(12):4592-4600. (Pubitemid 34627232)
73. Chung B, Barbara-Burnham L, Barsky L, Weinberg K. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood. 2001;98(5):1601-1606.
74. Williams KM, Mella H, Lucas PJ, Williams JA, Telford W, Gress RE. Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury. Clin Transl Sci. 2009;2(4):279-285.
75. Kelly RM, Goren EM, Taylor PA, et al. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood. 2010;115(5):1088-1097.
76. Goldberg GL, Dudakov JA, Reiseger JJ, et al. Sex steroid ablation enhances immune reconstitution following cytotoxic antineoplastic therapy in young mice. J Immunol. 2010;184(11):6014-6024.
77. Fletcher AL, Lowen TE, Sakkal S, et al. Ablation and regeneration of tolerance-inducing medullary thymic epithelial cells after cyclosporine, cyclophosphamide, and dexamethasone treatment. J Immunol. 2009;183(2):823-831.
78. Weinberg KI. Protection from posttransplantation immune deficiency? Blood. 2007;109(9):3617-3618. (Pubitemid 46641701)
79. Min D, Panoskaltsis-Mortari A, Kuro OM, Hollander GA, Blazar BR, Weinberg KI. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood. 2007;109(6):2529-2537. (Pubitemid 46425898)
80. Jeker LT, Barthlott T, Keller MP, et al. Maintenance of a normal thymic microenvironment and T-cell homeostasis require Smad4-mediated signaling in thymic epithelial cells. Blood. 2008;112(9):3688-3695.
81. Hauri-Hohl MM, Zuklys S, Keller MP, et al. TGF-beta signaling in thymic epithelial cells regulates thymic involution and postirradiation reconstitution. Blood. 2008;112(3):626-634.
82. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332(3):143-149.
83. Sykes M, Szot GL, Swenson K, Pearson DA, Wekerle T. Separate regulation of peripheral hematopoietic and thymic engraftment. Exp Hematol. 1998;26(6):457-465. (Pubitemid 28247311)
84. Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med. 2008;57(4):177-183.
85. Socie G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327-4336.
86. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561.
87. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995;86:3979-3986.
88. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139-170. (Pubitemid 46697905)
89. Ferrara JLM. GVHD: in vivo veritas. Blood. 2006;106(3):772-773. (Pubitemid 41076410)
90. Aguila HL. Hematopoietic niches: targets of GVHD. Blood. 2010;115(26):5284-5285.
91. Beschorner WE, Hutchins GM, Elfenbein GJ, Santos GW. The thymus in patients with allogeneic bone marrow transplants. Am J Pathol. 1978;92:173-181.
92. Lin MT, Tseng LH, Frangoul H, et al. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood. 2000;95(12):3832-3839. (Pubitemid 30412857)
93. Dulude G, Roy DC, Perreault C. The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med. 1999;189(8):1329-1342.
94. Ghayur T, Seemayer T, Lapp WS, et al. Histologic correlates of immune functional deficits in graft-vs-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K, eds. Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment. New York, NY: Marcel Dekker; 1990:109-132.
95. Hauri-Hohl MM, Keller MP, Gill J, et al. Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood. 2007;109(9):4080-4088. (Pubitemid 46641764)
96. Chu YW, Gress RE. Murine models of chronic graft-versus-host disease: insights and unresolved issues. Biol Blood Marrow Transplant. 2008;14(4):365-378.
97. Daikeler T, Tyndall A. Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol. 2007;20(2):349-360. (Pubitemid 46585970)
98. + T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood. 2006;107:2993-3001.
99. Holländer GA, Krenger W, Blazar BR. Emerging strategies to boost thymic function. Curr Opin Pharmacol. 2010;10(4):443-453.